ArticleCancer gene therapy2016

Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.

K Hasegawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.